-
Signature
-
/s/ Carl A. Hess by Lina Vanessa Jaramillo, Attorney-in-Fact (power of attorney previously filed)
-
Issuer symbol
-
WTW
-
Transactions as of
-
08 May 2025
-
Net transactions value
-
-$3,091,316
-
Form type
-
4
-
Filing time
-
12 May 2025, 16:02:15 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Hess Carl Aaron |
Chief Executive Officer, Director |
C/O WILLIS GROUP LIMITED, 51 LIME STREET, LONDON, UNITED KINGDOM |
/s/ Carl A. Hess by Lina Vanessa Jaramillo, Attorney-in-Fact (power of attorney previously filed) |
12 May 2025 |
0001435988 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
WTW |
Ordinary Shares, nominal value $0.000304635 per share |
Sale |
$44,800 |
-146 |
-0.15% |
$306.85 |
95,838 |
08 May 2025 |
Direct |
F1, F2 |
| transaction |
WTW |
Ordinary Shares, nominal value $0.000304635 per share |
Sale |
$59,118 |
-192 |
-0.2% |
$307.91 |
95,646 |
08 May 2025 |
Direct |
F1, F3 |
| transaction |
WTW |
Ordinary Shares, nominal value $0.000304635 per share |
Sale |
$1,871,827 |
-6,062 |
-6.3% |
$308.78 |
89,584 |
08 May 2025 |
Direct |
F1, F4 |
| transaction |
WTW |
Ordinary Shares, nominal value $0.000304635 per share |
Sale |
$895,256 |
-2,891 |
-3.2% |
$309.67 |
86,693 |
08 May 2025 |
Direct |
F1, F5 |
| transaction |
WTW |
Ordinary Shares, nominal value $0.000304635 per share |
Sale |
$220,314 |
-709 |
-0.82% |
$310.74 |
85,984 |
08 May 2025 |
Direct |
F1, F6 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: